Q2 2025 Kenvue Inc Earnings Call Transcript
Key Points
- Kenvue Inc (KVUE) has made significant leadership changes, including appointing Kirk Perry as Interim CEO and Amit Banati as CFO, to drive strategic growth.
- The company is focusing on simplifying operations by reducing complexity, which includes streamlining SKUs and focusing on core brands.
- Kenvue Inc (KVUE) has a robust pipeline of innovation, particularly in the back half of the year, which is expected to drive growth.
- The company is leveraging its iconic brand portfolio, such as Tylenol and Neutrogena, which have shown positive market share trends.
- Kenvue Inc (KVUE) is actively working on improving execution and financial performance, with a focus on consumer-centric strategies and market share growth.
- Kenvue Inc (KVUE) reported a 4.2% decline in organic sales for Q2 2025, which was below expectations.
- The company faced challenges in its self-care segment due to unfavorable seasonal and customer inventory dynamics.
- There is significant complexity within the organization, including a long tail of SKUs that contribute minimally to sales.
- Kenvue Inc (KVUE) is experiencing underperformance in key regions such as North America and Asia Pacific.
- The company has revised its 2025 guidance to reflect a low single-digit decline in organic sales, indicating ongoing challenges in achieving growth.
Hello, and welcome to Kenvue's second quarter 2025 earnings conferencei call. (Operator Instructions) As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Sofya Tsinis, Head of Investor Relations for Kenvue.
Good morning, everyone, and welcome to Kenvue's second quarter 2025 earnings conference call. I'd like to extend a special welcome to Kirk Perry, Interim Chief Executive Officer; and Amit Banati, Chief Financial Officer, as they participate in their first earnings call with us today.
Before we get started, I'd like to remind you that today's call includes forward-looking statements regarding, among other things, our operating and financial performance, market opportunities and growth. These statements represent our current beliefs, expectations or assumptions about future events and are subject to various risks, uncertainties and changes that are difficult to predict and could cause our actual results to differ materially. For information regarding
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |

